Jelaska A - Search Results

1

Fibroblast heterogeneity in physiological conditions and fibrotic disease.

Jelaska A, Strehlow D, Korn JH. Jelaska A, et al. Springer Semin Immunopathol. 1999;21(4):385-95. Springer Semin Immunopathol. 1999. PMID: 10945032 Review.

2

Anti-Fas induces apoptosis and proliferation in human dermal fibroblasts: differences between foreskin and adult fibroblasts.

Jelaska A, Korn JH. Jelaska A, et al. J Cell Physiol. 1998 Apr;175(1):19-29. doi: 10.1002/(SICI)1097-4652(199804)175:1<19::AID-JCP3>3.0.CO;2-F. J Cell Physiol. 1998. PMID: 9491777

3

A potential role for protease nexin 1 overexpression in the pathogenesis of scleroderma.

Strehlow D, Jelaska A, Strehlow K, Korn JH. Strehlow D, et al. Among authors: jelaska a. J Clin Invest. 1999 Apr;103(8):1179-90. doi: 10.1172/JCI1918. J Clin Invest. 1999. PMID: 10207170 Free PMC article.

4

Role of apoptosis and transforming growth factor beta1 in fibroblast selection and activation in systemic sclerosis.

Jelaska A, Korn JH. Jelaska A, et al. Arthritis Rheum. 2000 Oct;43(10):2230-9. doi: 10.1002/1529-0131(200010)43:10<2230::AID-ANR10>3.0.CO;2-8. Arthritis Rheum. 2000. PMID: 11037882 Free article.

5

Heterogeneity of collagen synthesis in normal and systemic sclerosis skin fibroblasts. Increased proportion of high collagen-producing cells in systemic sclerosis fibroblasts.

Jelaska A, Arakawa M, Broketa G, Korn JH. Jelaska A, et al. Arthritis Rheum. 1996 Aug;39(8):1338-46. doi: 10.1002/art.1780390811. Arthritis Rheum. 1996. PMID: 8702442

6

Mast cells induce T-cell adhesion to human fibroblasts by regulating intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 expression.

Meng H, Marchese MJ, Garlick JA, Jelaska A, Korn JH, Gailit J, Clark RA, Gruber BL. Meng H, et al. Among authors: jelaska a. J Invest Dermatol. 1995 Dec;105(6):789-96. doi: 10.1111/1523-1747.ep12326075. J Invest Dermatol. 1995. PMID: 7490473 Free article.

7

Human mast cells activate fibroblasts: tryptase is a fibrogenic factor stimulating collagen messenger ribonucleic acid synthesis and fibroblast chemotaxis.

Gruber BL, Kew RR, Jelaska A, Marchese MJ, Garlick J, Ren S, Schwartz LB, Korn JH. Gruber BL, et al. Among authors: jelaska a. J Immunol. 1997 Mar 1;158(5):2310-7. J Immunol. 1997. PMID: 9036979

8

Impact of empagliflozin added on to basal insulin in type 2 diabetes inadequately controlled on basal insulin: a 78-week randomized, double-blind, placebo-controlled trial.

Rosenstock J, Jelaska A, Zeller C, Kim G, Broedl UC, Woerle HJ; EMPA-REG BASALTM trial investigators. Rosenstock J, et al. Among authors: jelaska a. Diabetes Obes Metab. 2015 Oct;17(10):936-48. doi: 10.1111/dom.12503. Epub 2015 Jul 14. Diabetes Obes Metab. 2015. PMID: 26040302 Free PMC article. Clinical Trial.

9

Improved glucose control with weight loss, lower insulin doses, and no increased hypoglycemia with empagliflozin added to titrated multiple daily injections of insulin in obese inadequately controlled type 2 diabetes.

Rosenstock J, Jelaska A, Frappin G, Salsali A, Kim G, Woerle HJ, Broedl UC; EMPA-REG MDI Trial Investigators. Rosenstock J, et al. Among authors: jelaska a. Diabetes Care. 2014 Jul;37(7):1815-23. doi: 10.2337/dc13-3055. Epub 2014 Jun 14. Diabetes Care. 2014. PMID: 24929430 Clinical Trial.

10

Efficacy and safety of tipranavir coadministered with ritonavir in HIV-1-infected children and adolescents: 5 years of experience.

Salazar JC, Cahn P, Della Negra M, De Aquino MZ, Robinson PA, Jelaska A, Mikl J. Salazar JC, et al. Among authors: jelaska a. Pediatr Infect Dis J. 2014 Apr;33(4):396-400. doi: 10.1097/INF.0000000000000038. Pediatr Infect Dis J. 2014. PMID: 23995585 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters